APA (7th ed.) Citation

Lam, J. R., Otabor, E., Alomari, L., Barnett, M., Subedi, B., Hirpara, H., & Thummar, F. (2025). Assessing gout risk associated with GLP‐1 therapy in obese patients with type 2 diabetes: A retrospective cohort study. Rheumatology & Autoimmunity, 5(3), 258. https://doi.org/10.1002/rai2.70015

Chicago Style (17th ed.) Citation

Lam, Justin Riley, Emmanuel Otabor, Laith Alomari, Maxim Barnett, Bal Subedi, Het Hirpara, and Freya Thummar. "Assessing Gout Risk Associated with GLP‐1 Therapy in Obese Patients with Type 2 Diabetes: A Retrospective Cohort Study." Rheumatology & Autoimmunity 5, no. 3 (2025): 258. https://doi.org/10.1002/rai2.70015.

MLA (9th ed.) Citation

Lam, Justin Riley, et al. "Assessing Gout Risk Associated with GLP‐1 Therapy in Obese Patients with Type 2 Diabetes: A Retrospective Cohort Study." Rheumatology & Autoimmunity, vol. 5, no. 3, 2025, p. 258, https://doi.org/10.1002/rai2.70015.